medigraphic.com
SPANISH

Salud Mental

ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 4

<< Back Next >>

Salud Mental 2020; 43 (4)

Cognitive and clinic profile of volatile substance users

Alonso-Matías L, Reyes-Zamorano E, González-Olvera JJ
Full text How to cite this article

Language: English
References: 47
Page: 167-174
PDF size: 449.91 Kb.


Key words:

Cognition, screening, craving, inhalants, addiction.

ABSTRACT

Introduction. Inhalant use disorder has increased in spite of its adverse medical consequences. Due to the inherent difficulties of working with this population, so far there has been no quantifiable clinical evidence of the cognitive characteristics of inhalants users in early withdrawal and the clinic effect of consumption time. Objective. To evaluate the clinical and cognitive performance of inhalant users and the clinic effects of consumption time. Method. A cross-sectional study in which 28 adult users of inhalants were included, divided in two groups according to their consumption time: less than or greater than seven years. They were all evaluated in terms of clinical and neuropsychological values. Results. Consumers of inhalant showed presence of craving (M = 479.14, SD = 213.51), altered frontal behavior before (M = 119.18, SD = 29.53) and now (M = 130, SD = 33.03), sleeping problems (M = 8.93, SD = 3.4), and cognitive difficulties (inhibitory control, planning, decision-making, working memory, verbal fluency, and cognitive flexibility); all these tasks were statistically significant (p = ‹ .05). Discussion and conclusion. Executive functioning is impaired with inhalant use disorder; these alterations increase with withdrawal and craving and changes remain independent from the use time.


REFERENCES

  1. Alfaro-Rodríguez, A., Bueno-Nava, A., González-Piña, R., Arch-Tirado, E., Vargas- Sánchez, J. & Ávila-Luna, A. (2011). Chronic exposure to toluene changes the sleep-wake pattern and brain monoamine content in rats. Acta Neurobiologiae Experimentalis, 71(2), 183-92.

  2. Alonso-Matías, L., Páez-Martínez, N., Reyes-Zamorano, E., & González-Olvera, J. J. (2015). Evidence of validity of an inhalant-craving questionnaire. Adicciones, 27(4), 276-287. Retrieved from http://www.adicciones.es/index.php/adicciones/ article/view/752

  3. Angarita, G. A, Emadi, N., Hodges, S., & Morgan, P. T. (2016). Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addiction Science & Clinical Practice, 11(1), 9. doi: 10.1186/s13722- 016-0056-7

  4. Balster, R. L., Cruz, S. L., Howard, M. O., Dell, C. A., & Cottler, L. B. (2009). Classification of abused inhalants. Addiction, 104(6), 878-882. doi: 10.1111/j.1360-0443.2008.02494.x

  5. Boak, A., Hamilton, H. A., Adlaf, E. M., & Mann, R. E. (2017). Drug use among Ontario students, 1977-2017: Detailed findings from the Ontario Student Drug Use and Health Survey (OSDUHS). (CAMH Research Document Series No. 46). Toronto, Ontario: Centre for Addiction and Mental Health. Retrieved from https://www.champlainpathways.ca/wp-content/uploads/2018/01/Detailed_ DrugUseReport_2017OSDUHS.pdf

  6. Bowen, S. E., Batis, J. C., Paez-Martinez, N., & Cruz, S. L. (2006). The last decade of solvent research in animal models of abuse: Mechanistic and behavioral studies. Neurotoxicology and Teratology, 28(6), 636-647. doi: 10.1016/j.ntt.2006.09.005

  7. Bresin, K., & Verona, E. (2019). Craving and substance use: Examining psychophysiological and behavioral moderators. International Journal of Psychophysiology. doi: 10.1016/j.ijpsycho.2019.03.006

  8. Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193-213. doi: 10.1016/0165- 1781(89)90047-4

  9. Calhoun, K., Wattenbarger, L., Burns, E., Hatcher, C., Patel, A., Badam, M., & Khan, A. (2018). Inhaling Difluoroethane Computer Cleaner Resulting in Acute Kidney Injury and Chronic Kidney Disease. Case Reports in Nephrology, 2018, 1-3. doi: 10.1155/2018/4627890

  10. Crossin, R., Cairney, S., Lawrence, A. J., & Duncan, J. R. (2017). Adolescent inhalant abuse leads to other drug use and impaired growth; implications for diagnosis. Australian and New Zealand Journal of Public Health, 41(1), 99-104. doi: 10.1111/1753-6405.12595

  11. Crunelle, C. L., van den Brink, W., Moggi, F., Konstenius, M., Franck, J., Levin, F. R., … Matthys, F. (2018). International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder. European Addiction Research, 24(1), 43-51. doi: 10.1159/000487767

  12. Cruz, S. L. (2011). The latest evidence in neuroscience of solvent misuse: an article written for service providers. Substance Use Misuse, 46(sup1), 62-67. doi: 10.3109/10826084.2011.580215

  13. Dingwall, K. M., Maruff, P., Fredrickson, A., & Cairney, S. (2011). Cognitive recovery during and after treatment for volatile solvent abuse. Drug and Alcohol Dependence, 118(2-3), 180-185. doi: 10.1016/j.drugalcdep.2011.03.017

  14. Dinsfriend, W., Rao, K., & Matulevicius, S. (2016). Inhalant-Abuse Myocarditis Diagnosed by Cardiac Magnetic Resonance. Texas Heart Institute Journal, 43(3), 246-248. doi: 10.14503/THIJ-14-4919

  15. Elkoussi, A., & Bakheet, S. (2011). Volatile substance misuse among street children in Upper Egypt. Substance Use & Misuse, 46(sup1), 35-39. doi: 10.3109/10826084.2011.580202

  16. Flores-Lázaro, J. C., Ostrosky-Shejet, F., & Lozano-Gutiérrez, A. (2012). Batería Neuropsicológica de Funciones Ejecutivas y Lóbulos Frontales (BANFE-2). México: Manual Moderno.

  17. Grace, J., & Malloy, P. (2001). Frontal Systems Behavior Scale (FrSBe): Professional Manual. Psychological Assessment Resources.

  18. Gromov, I., & Gromov, D. (2009). Sleep and Substance Use and Abuse in Adolescents. Child and Adolescent Psychiatric Clinics of North America, 18(4), 929-946. doi: 10.1016/j.chc.2009.04.004

  19. Guerin, N., & White, V. (2018). ASSAD 2017 Statistics & Trends: Australian Secondary Students’ Use of Tobacco, Alcohol, Over-the-counter Drugs, and Illicit Substances. Melbourne Victoria, Australia: Cancer Council Victoria. Retrieved from https://beta.health.gov.au/file/9756/ download?token=ApVLPOfY

  20. Hong, S., Choi, E., Kim, H., Suh, J., Takagi, M. J., Lubman, D. I., … Yücel, M. (2014). Decreased thalamic volumes in adolescent inhalant users from Korea and Australia. The World Journal Biological Psychiatry, 15(8), 636-640. doi: 10.3109/15622975.2014.902540

  21. Howard, M. O., Bowen, S. E., Garland, E. L., Perron, B. E., & Vaughn, M. G. (2011). Inhalant use and inhalant use disorders in the United States. Addiction Science & Clinical Practice, 6(1), 18-31.

  22. Hynes-Dowell, M., Mateu-Gelabert, P., Barros, H. M. T., & Delva, J. (2011). Volatile Substance Misuse Among High School Students in South America. Substance Use & Misuse, 46(sup1), 27-34. doi: 10.3109/10826084.2011.580192

  23. Jiménez-Genchi, A., Monteverde-Maldonado, E., Nenclares-Portocarrero, A., Esquivel-Adame, G., & de la Vega-Pacheco A. (2008). Reliability and factorial analysis of the Spanish version of the Pittsburg Sleep Quality Index among psychiatric patients. Gaceta Médica de México, 144(6), 491-496. Retrieved from https://europepmc.org/article/med/19112721

  24. Johnston, L. D., Miech, R. A., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2017). Monitoring the Future national survey results on drug use, 1975-2017: Overview, Key Findings on Adolescent Drug use. Ann Arbor: Institute for Social Research, University of Michigan.

  25. Kharb, R., Shekhawat, L. S., Beniwal, R. P., Bhatia, T., & Deshpande, S. N. (2018). Relationship between Craving and Early Relapse in Alcohol Dependence: A Short-Term Follow-up Study. Indian Journal of Psychological Medicine, 40(4), 315-321. doi: 10.4103/IJPSYM.IJPSYM_558_17

  26. Kurtzman, T. L., Otsuka, K. N., & Wahl, R. A. (2001). Inhalant abuse by adolescents. Journal of Adolescent Health, 28(3), 170-180. doi: 10.1016/S1054- 139X(00)00159-2

  27. Marín-Navarrete, R., Toledo-Fernández, A., Villalobos-Gallegos, L., Pérez-López, A., & Medina-Mora, M. E. (2018). Neuropsychiatric characterization of individuals with inhalant use disorder and polysubstance use according to latent profiles of executive functioning. Drug and Alcohol Dependence, 190, 104-111. doi: 10.1016/j.drugalcdep.2018.06.005

  28. Mollayeva, T., Thurairajah, P., Burton, K., Mollayeva, S., Shapiro, C. M., & Colantonio, A. (2016). The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Medicine Reviews, 25, 52-73. doi: 10.1016/j. smrv.2015.01.009

  29. National Institute on Drug Abuse [NIDA]. (2012). Research Report Series: Inhalant Abuse. Retrieved from http://www.drugabuse.gov/publications/researchreports/ inhalant-abuse

  30. O’Sullivan, M., Barrick, T. R., Morris, R. G., Clark, C. A., & Markus, H. S. (2005). Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology, 65(10), 1584-1590. doi: 10.1212/01. wnl.0000184480.07394.fb

  31. Paliwal, P., Hyman, S. M., & Sinha, R. (2008). Craving predicts time to cocaine relapse: Further validation of the Now and Brief versions of the Cocaine Craving Questionnaire. Drug and Alcohol Dependence, 93(3), 252-259. doi: 10.1016/j.drugalcdep.2007.10.002

  32. Pedrero-Pérez, E. J., Ruiz-Sánchez de León, J. M., Llanero-Luque, M., Rojo-Mota, G., Olivar-Arroyo, A., & Puerta-García, C. (2009). Sintomatología frontal en adictos a sustancias en tratamiento mediante la versión española de la escala de comportamiento frontal. Revista de Neurología, 48(12), 624-631. doi: 10.33588/rn.4812.2008654

  33. Perron, B. E. & Howard, M. O. (2009). Adolescent inhalant use, abuse and dependence. Addiction Research Report, 104(7), 1185-1192. doi: 10.1111/j.1360-0443.2009.02557.x

  34. Petit, G., Luminet, O., Cordovil de Sousa Uva, M., Monhonval, P., Leclercq, S., Spilliaert, Q., … de Timary, P. (2017). Gender Differences in Affects and Craving in Alcohol-Dependence: A Study During Alcohol Detoxification. Alcoholism: Clinical and Experimental Research, 41(2), 421-431. doi: 10.1111/ acer.13292

  35. Ribas-Siñol, M., del Prado-Sanchez, N., Claramunt-Mendoza, J., Civit-Ramirez, M., Canalias-Perez, O., & Ochoa, S. (2015). Troubled adolescents: substance abuse and mental disorder in young offenders. Actas Españolas de Psiquiatría, 43(6), 197-204. Retrieved from https://www.actaspsiquiatria.es/repositorio/17/98/ ENG/17-98-ENG-197-204-226633.pdf

  36. Seo, D., & Sinha, R. (2014). Chapter 21: The neurobiology of alcohol craving and relapse. Handbook of Clinical Neurology, 125, 355-368. doi: 10.1016/B978-0- 444-62619-6.00021-5

  37. Spinella, M. (2003). Relationship between drug use and prefrontal associated traits. Addiction Biology, 8(1), 67-74. doi: 10.1080/1355621031000069909

  38. Stout, J. C., Ready, R. E., Grace, J., Malloy, P. F., & Paulsen, J. S. (2003). Factor analysis of the Frontal Systems Behavior Scale (FrSBe). Assessment, 10(1), 79- 85. doi: 10.1177/1073191102250339

  39. Takagi, M., Lubman, D. I., Walterfang, M., Barton, S., Reutens, D., Wood, A., & Yücel, M. (2013). Corpus callosum size and shape alterations in adolescent inhalant users. Addiction Biology, 18(5), 851-854. doi: 10.1111/j.1369- 1600.2011.00364.x

  40. Terán-Pérez, G., Arana, Y., Paredes, L., Atilano-Barbosa, D., Velázquez-Moctezuma, J., & Mercadillo, R. E. (2020). Diverse sleep patterns, psychiatric disorders, and perceived stress in inhalants users living on the streets of Mexico City. Sleep Health, 6(2), 192-196. doi: 10.1016/j.sleh.2019.11.005

  41. Važan, P., Khan, M. R., Poduška, O., Št’astná, L., & Miovský, M. (2011). Chronic toluene misuse among Roma Youth in Eastern Slovakia. Substance Use & Misuse, 46(sup1), 57-61. doi: 10.3109/10826084.2011.580213

  42. Verdejo-García, A., Aguilar de Arcos, F., & Pérez-García, M. (2004). Alteraciones de los procesos de toma de decisiones vinculados al córtex prefrontal ventromedial en pacientes drogodependientes. Revista de Neurología, 38(7), 601-606. doi: 10.33588/rn.3807.2003639

  43. Verdejo-García, A., Rivas-Pérez, C., López-Torrecillas, F., & Pérez-García, M. (2006). Differential impact of severity of drug use on frontal behavioral symptoms. Addictive Behaviors, 31(8), 1373-1382. doi: 10.1016/j.addbeh.2005.11.003

  44. Villatoro-Velázquez, J. A., Resendiz-Escobar, E., Mujica-Salazar, A., Bretón-Cirett, M., Cañas-Martínez, V., Soto-Hernández, I., … Mendoza-Alvarado, L. (2017). Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017: Reporte de Drogas. Ciudad de México, México: Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz; Instituto Nacional de Salud Pública, Comisión Nacional Contra las Adicciones, Secretaría de Salud. Retrieved from https:// encuestas.insp.mx/ena/encodat2017/reporte_encodat_drogas_2016_2017.pdf

  45. Weiss, R. D., Griffin, M. L., Mazurick, C., Berkman, B., Gastfriend, D. R., Frank, A., … Moras, K. (2003). The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. American Journal of Pychiatry, 160(7), 1320-1325. doi: 10.1176/appi.ajp.160.7.1320

  46. Yücel, M., Takagi, M., Walterfang, M., & Lubman, D. I. (2008). Toluene misuse and long-term harms: A systematic review of the neuropsychological and neuroimaging literature. Neuroscience Biobehavioral Reviews, 32(5), 910-926. doi: 10.1016/j.neubiorev.2008.01.006

  47. Zarrouq, B., Bendaou, B., El Asri, A., Achour, S., Rammouz, I., Aalouane, R., … El Rhazi, K. (2016). Psychoactive substances use and associated factors among middle and high school students in the North Center of Morocco: a crosssectional questionnaire survey. BMC Public Health, 16(1), 468. doi: 10.1186/ s12889-016-3143-5




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Salud Mental. 2020;43